300267.SZ
尔康制药
SZSE · Healthcare · C 制造业 · CN
CNY 3.17
−1.55%Jul 22, 2026, 12:53 UTC
Erkang Pharmaceutical's controlling shareholder Shuai Fangwen completed a share reduction plan, selling 10.776 million shares via centralized bidding at an average price of 4.38 yuan per share.